|
gptkbp:instanceOf
|
gptkb:drug
nonsteroidal antiandrogen
|
|
gptkbp:approvedBy
|
1983
|
|
gptkbp:ATCCode
|
L02BB01
|
|
gptkbp:CASNumber
|
13311-84-7
|
|
gptkbp:chemicalClass
|
anilide
trifluoromethyl compound
|
|
gptkbp:contraindication
|
severe hepatic impairment
|
|
gptkbp:developedBy
|
gptkb:Schering-Plough
|
|
gptkbp:discoveredIn
|
1967
|
|
gptkbp:eliminationHalfLife
|
5-6 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:hasMolecularFormula
|
C11H11F3N2O3
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
flutamide
|
|
gptkbp:KEGGID
|
D00436
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedIn
|
gptkb:Europe
gptkb:Japan
gptkb:United_States
|
|
gptkbp:mechanismOfAction
|
androgen receptor antagonist
|
|
gptkbp:meltingPoint
|
110-113°C
|
|
gptkbp:MeSH_ID
|
D005651
|
|
gptkbp:metabolism
|
2-hydroxyflutamide
|
|
gptkbp:notRecommendedFor
|
gptkb:women
children
|
|
gptkbp:pregnancyCategory
|
gptkb:X_(Australia)
D (US)
|
|
gptkbp:proteinBinding
|
94-96%
|
|
gptkbp:PubChem_CID
|
gptkb:CHEMBL1423
3257
3373
DB00499
|
|
gptkbp:riskFactor
|
gptkb:anemia
gptkb:methemoglobinemia
hepatotoxicity
photosensitivity
male infertility
interstitial pneumonitis
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
diarrhea
fatigue
elevated liver enzymes
liver toxicity
gynecomastia
hot flashes
|
|
gptkbp:synonym
|
Eulexin
|
|
gptkbp:UNII
|
G3X371W164
|
|
gptkbp:usedFor
|
prostate cancer
androgen-dependent conditions
|
|
gptkbp:bfsParent
|
gptkb:Androgen_receptor
gptkb:androgen_receptor
|
|
gptkbp:bfsLayer
|
7
|